Physician profile
Thomas Hardacker
NPI 1952797144
$3,536.31
in general payments reported to CMS, 2019-2025
31 companies · $925 in 2025
The $925 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2021: $251 · 2022: $905 · 2023: $374 · 2024: $600 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,864 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,864.08 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,192.10 | 2019-2025 | Lumenis Pulse 120h, Rezum Generator, General - Kidney Stone Disease |
| Medtronic USA, INC. | $377.10 | 2019 | |
| Coloplast Corp | $362.44 | 2021-2025 | |
| Pfizer INC. | $295.03 | 2022-2025 | |
| Histosonics, INC. | $258.07 | 2025 | |
| Bioprotect Medical, INC. | $105.20 | 2025 | Bioprotect Balloon Implant System |
| Calyxo, INC. | $96.71 | 2024-2025 | Cvac Aspiration System |
| Photocure INC | $94.83 | 2021 | |
| Myriad Genetic Laboratories, INC. | $72.29 | 2024-2025 | Prolaris |
| Urovant Sciences INC | $66.98 | 2022 | |
| Medtronic, INC. | $61.73 | 2022-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $52.16 | 2023-2024 | Gemtesa, Orgovyx |
| Progenics Pharmaceuticals, INC. | $46.97 | 2023-2025 | Pylarify |
| Sun Pharmaceutical Industries INC. | $45.72 | 2023 | Yonsa |
| Merck Sharp & Dohme LLC | $43.50 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $39.96 | 2023-2025 | Itind System, Olympus |
| Koelis INC. | $37.26 | 2024 | |
| Urogen Pharma, INC. | $36.87 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $35.06 | 2025 | Imfinzi |
| Vertex Pharmaceuticals Incorporated | $24.20 | 2025 | |
| Accord Healthcare, INC. | $23.66 | 2024 | |
| Verity Pharmaceuticals INC. | $23.65 | 2025 | Trelstar |
| Tolmar, INC. | $19.79 | 2024 | |
| Cycle Pharmaceuticals INC | $17.78 | 2025 | Venxxiva |
| Myovant Sciences INC. | $17.39 | 2022 | |
| Teleflex LLC | $16.75 | 2024 | Urolift |
| Janssen Biotech, INC. | $16.25 | 2023 | Erleada |
| Astellas Pharma US INC | $14.97 | 2023 | Myrbetriq |
| Immunitybio, INC. | $14.96 | 2024 | |
| Becton, Dickinson and Company | $13.86 | 2024 | Bard Urinary Drainage Bag |
| Bayer Healthcare Pharmaceuticals INC. | $13.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hardacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.